Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

RSS icon

Rivaroxaban limits adverse limb and cardiovascular events in surgically treated PAD patients

Rivaroxaban was associated with more bleeding than a placebo, researchers observed, but the overall incidence of such events was still low.

Statin use prior to hospitalization linked to lower COVID-19 mortality

The trend is particularly noticeable in patients with a history of CVD or hypertension.

Chronic liver disease associated with worse PCI outcomes

Researchers tracked data from more than 54,000 adult patients with CLD who underwent PCI from 2004 to 2015.

Thumbnail

FDA pushes for statin warnings to be updated

It has long been believed that patients should not take statins while they are pregnant. Now, however, the FDA is emphasizing that there are certain exceptions to that rule.

Thumbnail

Prasugrel outperforms ticagrelor among PCI patients

The study's authors tracked data from more than 3,000 patients who underwent PCI for acute coronary syndrome.

Thumbnail

Ticagrelor vs. prasugrel for severe heart attack patients undergoing PCI

A new study, published in Circulation, tracked how each drug helped STEMI patients undergoing primary PCI. 

Thumbnail

Skip the clopidogrel? TAVR patients benefit from antiplatelet therapy that includes aspirin only

The risk of major bleeding or life-threatening bleeding events was higher when clopidogrel was included in the patient's treatment strategy. 

Thumbnail

How ticagrelor or clopidogrel use can impact PCI outcomes

The authors tracked data from more than 62,000 adult patients who received treatment from November 2011 to March 2019.

Displaying 257 - 264 of 290

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup